High expression of MRPL52 can be used as a prognostic marker of hepatocellular carcinoma and is related to immune infiltration-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

High expression of MRPL52 can be used as a prognostic marker of hepatocellular carcinoma and is related to immune infiltration

Published:2021-12 Issue:4 Volume:2 Page:326-340
ISSN:2707-3688
Container-title:Journal of Holistic Integrative Pharmacy
language:en
Short-container-title:Journal of Holistic Integrative Pharmacy

Author:

HUANG Nan,LIU Xiang,XING Qichang,CHEN Jia,GUO Xiaolan,LI Wei,LIU Zheng

Publisher

Elsevier BV

Reference31 articles.

1. The global burden of cancer 2013[J];Fitzmaurice;JAMA Oncol,2015

2. Population attributable fractions of risk factors for hepatocellular carcinoma in the United States[J];Makarova-Rusher;Cancer,2016

3. Randomized controlled trial of screening for hepatocellular carcinoma[J];Zhang;J Cancer Res Clin Oncol,2004

4. Global burden of disease liver cancer collaboration. the burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: results from the global burden of disease study 2015[J];Akinyemiju;JAMA Oncol,2017

5. Hepatocellular carcinoma in cirrhosis: incidence and risk factors[J];Fattovich;Gastroenterology,2004

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP